X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HUL - Comparison Results

HUL 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HUL AMAR REMEDIES/
HUL
 
P/E (TTM) x -0.5 63.0 - View Chart
P/BV x 0.1 48.3 0.1% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 AMAR REMEDIES   HUL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HUL
Mar-19
AMAR REMEDIES/
HUL
5-Yr Chart
Click to enlarge
High Rs1641,871 8.8%   
Low Rs861,322 6.5%   
Sales per share (Unadj.) Rs261.6181.6 144.1%  
Earnings per share (Unadj.) Rs17.428.0 62.1%  
Cash flow per share (Unadj.) Rs22.330.6 72.8%  
Dividends per share (Unadj.) Rs022.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs100.736.3 277.1%  
Shares outstanding (eoy) m26.162,164.53 1.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.58.8 5.4%   
Avg P/E ratio x7.257.0 12.6%  
P/CF ratio (eoy) x5.652.1 10.8%  
Price / Book Value ratio x1.243.9 2.8%  
Dividend payout %078.6 0.0%   
Avg Mkt Cap Rs m3,2703,454,698 0.1%   
No. of employees `000NA5.6 0.0%   
Total wages/salary Rs m16318,750 0.9%   
Avg. sales/employee Rs ThNM69,636.8-  
Avg. wages/employee Rs ThNM3,321.5-  
Avg. net profit/employee Rs ThNM10,735.2-  
INCOME DATA
Net Sales Rs m6,844393,100 1.7%  
Other income Rs m215,500 0.4%   
Total revenues Rs m6,865398,600 1.7%   
Gross profit Rs m1,13188,800 1.3%  
Depreciation Rs m1285,650 2.3%   
Interest Rs m398330 120.6%   
Profit before tax Rs m62688,320 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,280 2.2%   
Tax Rs m12125,440 0.5%   
Profit after tax Rs m45560,600 0.8%  
Gross profit margin %16.522.6 73.2%  
Effective tax rate %19.328.8 67.1%   
Net profit margin %6.615.4 43.1%  
BALANCE SHEET DATA
Current assets Rs m4,904119,140 4.1%   
Current liabilities Rs m3,58186,670 4.1%   
Net working cap to sales %19.38.3 234.0%  
Current ratio x1.41.4 99.6%  
Inventory Days Days12424 519.9%  
Debtors Days Days10017 594.0%  
Net fixed assets Rs m1,68951,210 3.3%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35876,510 3.1%   
Net worth Rs m2,63578,670 3.3%   
Long term debt Rs m5070-   
Total assets Rs m6,862186,290 3.7%  
Interest coverage x2.6268.6 1.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.1 47.3%   
Return on assets %12.432.7 38.0%  
Return on equity %17.377.0 22.4%  
Return on capital %31.0109.8 28.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2733,240 8.4%   
Fx outflow Rs m213,820 0.0%   
Net fx Rs m271-10,580 -2.6%   
CASH FLOW
From Operations Rs m-31358,000 -0.5%  
From Investments Rs m-489-4,380 11.2%  
From Financial Activity Rs m769-53,900 -1.4%  
Net Cashflow Rs m-33-280 11.6%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  RELAXO FOOTWEARS  BAJAJ CONSUMER CARE  MARICO  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends Over 300 Points Higher; Energy and Metal Stocks Witness Buying(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

HUL 2018-19 Annual Report Analysis (Annual Result Update)

Jun 7, 2019 | Updated on Jun 7, 2019

Here's an analysis of the annual report of HUL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of HUL. Also includes updates on the valuation of HUL.

HUL Announces Quarterly Results (4QFY19); Net Profit Up 13.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, HUL has posted a net profit of Rs 15 bn (up 13.8% YoY). Sales on the other hand came in at Rs 99 bn (up 9.3% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (3QFY19); Net Profit Up 8.9% (Quarterly Result Update)

Jan 18, 2019 | Updated on Jan 18, 2019

For the quarter ended December 2018, HUL has posted a net profit of Rs 14 bn (up 8.9% YoY). Sales on the other hand came in at Rs 96 bn (up 11.3% YoY). Read on for a complete analysis of HUL's quarterly results.

HIND. UNILEVER Announces Quarterly Results (2QFY19); Net Profit Up 19.5% (Quarterly Result Update)

Oct 15, 2018 | Updated on Oct 15, 2018

For the quarter ended September 2018, HIND. UNILEVER has posted a net profit of Rs 15 bn (up 19.5% YoY). Sales on the other hand came in at Rs 92 bn (up 11.1% YoY). Read on for a complete analysis of HIND. UNILEVER's quarterly results.

HIND. UNILEVER 2017-18 Annual Report Analysis (Annual Result Update)

Aug 9, 2018 | Updated on Aug 9, 2018

Here's an analysis of the annual report of HIND. UNILEVER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of HIND. UNILEVER. Also includes updates on the valuation of HIND. UNILEVER.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS